energias.jpg
Rising Prevalence of Neurological Diseases Driving the Neuromodulation Devices Market Growth; to Witness a CAGR of 10.3% during 2019-2025
June 04, 2019 09:23 ET | Energias Market Research
NEW YORK, June 04, 2019 (GLOBE NEWSWIRE) -- The global neuromodulation devices market is expected to grow significantly from USD 5,120 Million in 2018 to USD 10,200 Million in 2025, at a CAGR of...
MicroTransponder Clinical Trial Results Published in Stroke After Company Completes a $5.5M Round of Funding
December 10, 2015 11:58 ET | MicroTransponder
DALLAS, TX--(Marketwired - December 10, 2015) - MicroTransponder, Inc., (www.microtransponder.com) a privately-held medical device company, is pleased to announce that its successful stroke...